Caffeinated Capital

Overview

Caffeinated Capital is a U.S.-based venture capital firm headquartered in San Francisco with operations in New York. It invests in technology companies across stages, leading seed and Series A rounds while providing support throughout the company lifecycle, with a focus on contrarian bets in areas like AI, deeptech, biotech, and defense.¹²³

History

Founded in 2009, Caffeinated Capital operates as an independent firm specializing in early-stage venture investments.¹ The firm partners with founders from inception and invests through later stages, emphasizing long-term thinking over hype cycles.³⁴ Key investments include leading Airtable’s Series B, Saronic’s Series A, Varda’s Series A and B, and early stakes in Virta Health and Aven.⁴

Notable Products

• Airtable Series B - Led investment in Airtable when no other investors were interested.
• Saronic Series A - Led Series A in defense tech company before the sector gained popularity.
• Varda Series A and B - Co-led Series A and led Series B prior to first space launch.
• Virta Health early investment - First and largest investor before scaling its care model.
• Aven early investment - First and largest investor after consumer lending fell out of favor.

Reputation

Caffeinated Capital is recognized for taking contrarian positions in frontier technologies like orbital manufacturing, nuclear space infrastructure, and defense, often leading rounds in overlooked areas.²⁴ Professionals note its thesis- and stage-agnostic approach with check sizes of $100K-$500K in seed to Series B+ rounds across AI, Web3, deeptech, and biotech.² It is perceived as offering founders long-term support, distinguishing it from hype-driven firms.³⁴